| Literature DB >> 27461601 |
Gokmen Umut Erdem1, Mutlu Dogan1, Nebi Serkan Demirci1, Nurullah Zengin1.
Abstract
Oxaliplatin (1, 2-diamminocyclohexaneoxalato-platinum) is a novel platin analog, which is widely used in gastrointestinal malignancies. Platinum analogs damage cellular deoxyribonucleic acid (DNA) by leading covalent bifunctional DNA adducts with cellular DNA. Major side effects of oxaliplatin are neurotoxicity (peripheral neuropathy), myelosuppression with moderate thrombocytopenia and gastrointestinal toxicity (diarrhea). Thrombocytopenia might be related to myelosuppression and/or drug-induced immune thrombocytopenia (DIIT). In here, oxaliplatin-induced thrombocytopenia is discussed with review of the literature.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27461601 DOI: 10.4103/0973-1482.154056
Source DB: PubMed Journal: J Cancer Res Ther ISSN: 1998-4138 Impact factor: 1.805